Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 10 Mar 2016
At a glance
- Drugs Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms STREAM
- 07 Jun 2017 Biomarkers information updated
- 07 Mar 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 16 Apr 2014 According to ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.